Related Experiment Video
Updated: Sep 29, 2025

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses
Published on: March 8, 2024
Nucleic Acid-Based COVID-19 Therapy Targeting Cytokine Storms: Strategies to Quell the Storm
Mai Abdel Haleem Abusalah1, Moad Khalifa2, Mohammad A I Al-Hatamleh3
1Department of Medical Microbiology and Parasitology, School of Medical Sciences, Universiti Sains Malaysia, Kota Bharu 16150, Kelantan, Malaysia.
Abstract:
Coronavirus disease 2019 (COVID-19) has shaken the world and triggered drastic changes in our lifestyle to control it. Despite the non-typical efforts, COVID-19 still thrives and plagues humanity worldwide. The unparalleled degree of infection has been met with an exceptional degree of research to counteract it. Many drugs and therapeutic technologies have been repurposed and discovered, but no groundbreaking antiviral agent has been introduced yet to eradicate COVID-19 and restore normalcy. As lethality is directly correlated with the severity of disease, hospitalized severe cases are of the greatest importance to reduce, especially the cytokine storm phenomenon. This severe inflammatory phenomenon characterized by elevated levels of inflammatory mediators can be targeted to relieve symptoms and save the infected patients. One of the promising therapeutic strategies to combat COVID-19 is nucleic acid-based therapeutic approaches, including microRNAs (miRNAs). This work is an up-to-date review aimed to comprehensively discuss the current nucleic acid-based therapeutics against COVID-19 and their mechanisms of action, taking into consideration the emerging SARS-CoV-2 variants of concern, as well as providing potential future directions. miRNAs can be used to run interference with the expression of viral proteins, while endogenous miRNAs can be targeted as well, offering a versatile platform to control SARS-CoV-2 infection. By targeting these miRNAs, the COVID-19-induced cytokine storm can be suppressed. Therefore, nucleic acid-based therapeutics (miRNAs included) have a latent ability to break the COVID-19 infection in general and quell the cytokine storm in particular.
Insights
Nucleic acid-based therapies, including microRNAs (miRNAs), show promise for combating COVID-19 by targeting viral proteins and suppressing the cytokine storm. These approaches offer a versatile strategy against SARS-CoV-2 infection and its severe complications.
Area of Science:
- Biotechnology
- Virology
- Molecular Biology
Background:
- The COVID-19 pandemic necessitates novel therapeutic strategies due to the limitations of current treatments.
- Severe COVID-19 cases are characterized by a dangerous cytokine storm, a key target for intervention.
- Nucleic acid-based therapeutics, particularly microRNAs (miRNAs), are emerging as promising antiviral agents.
Purpose of the Study:
- To review current nucleic acid-based therapeutics for COVID-19.
- To discuss the mechanisms of action of these therapies, including miRNAs.
- To consider emerging SARS-CoV-2 variants and future research directions.
Main Methods:
- Comprehensive literature review of nucleic acid-based therapeutics against COVID-19.
- Analysis of miRNA-based strategies targeting viral gene expression and host responses.
- Evaluation of therapeutic potential against SARS-CoV-2 variants and cytokine storm.
Main Results:
- miRNAs can interfere with viral protein expression and modulate host responses.
- Targeting specific miRNAs can suppress the COVID-19-induced cytokine storm.
- Nucleic acid therapeutics offer a versatile platform for controlling SARS-CoV-2 infection.
Conclusions:
- Nucleic acid-based therapeutics, including miRNAs, hold significant potential for treating COVID-19.
- These approaches can effectively combat viral infection and mitigate severe inflammatory responses.
- Further research into nucleic acid therapies is crucial for developing effective treatments against current and future SARS-CoV-2 variants.
Related Concept Videos
Tumor Immunotherapy
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Methods of reducing fever
Pharmacological Methods of Reducing Fever:
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Microorganisms in Medicine and Therapeutics
Targeted Cancer Therapies
There are several types of targeted therapies against...

